Listen "Stock Talk Podcast Episode 162"
Episode Synopsis
We are back this week to look at the crazy volatility – mostly to the downside - in North American markets have produced to start 2022. Ryan takes a brief look at the yo-yo action in a number of well-known tech stocks over the past week including Microsoft Corporation (MSFT: NASDAQ), Alphabet (GOOG: NASDAQ) (Google), Apple Inc. (AAPL: NASDAQ), and Amazon.com Inc. (AMZN: NASDAQ) on the plus side and Netflix Inc. (NFLX: NASDAQ), Meta Platforms Inc. (FB: NASDAQ) (Facebook), PayPal Holdings Inc. (PYPL: NASDAQ) and the rest of Tech generally, on the negative side.
From our mailbag, Ryan answers a question on Cathie Wood’s ARK Innovation ETF (ARKK). Aaron reviews what went wrong this week with Meta Platforms owner Facebook, the largest social media platform in the world, with 2.9 billion money active users. Meta dropped nearly 26% Thursday after the release of its fourth-quarter results – in a historical loss. Aaron, let’s you know why. Finally, Brennan answers a listener question on EcoSynthetix Inc. (ECO: TSX), which offers a range of sustainable engineered biopolymers that allow customers to reduce their use of harmful materials, such as formaldehyde and styrene-based chemicals. The stock has pulled back to start 2022 but has posted positive gains over the last year and five-year periods. Brennan examines whether the fundamentals of the business justify the gains.
From our mailbag, Ryan answers a question on Cathie Wood’s ARK Innovation ETF (ARKK). Aaron reviews what went wrong this week with Meta Platforms owner Facebook, the largest social media platform in the world, with 2.9 billion money active users. Meta dropped nearly 26% Thursday after the release of its fourth-quarter results – in a historical loss. Aaron, let’s you know why. Finally, Brennan answers a listener question on EcoSynthetix Inc. (ECO: TSX), which offers a range of sustainable engineered biopolymers that allow customers to reduce their use of harmful materials, such as formaldehyde and styrene-based chemicals. The stock has pulled back to start 2022 but has posted positive gains over the last year and five-year periods. Brennan examines whether the fundamentals of the business justify the gains.
More episodes of the podcast KeyStone’s Stock Talk – Canadian & US Small-Cap Growth & Dividend Stocks, Tips & Portfolio Building Strategies
Stock Talk Podcast Episode 316
04/11/2025
Stock Talk Podcast Episode 315
28/10/2025
Stock Talk Podcast Episode 314
21/10/2025
Stock Talk Podcast Episode 313
15/10/2025
Stock Talk Podcast Episode 312
10/10/2025
Stock Talk Podcast Episode 311
23/09/2025
Stock Talk Podcast Episode 310
18/09/2025
Stock Talk Podcast Episode 309
09/09/2025
Stock Talk Podcast Episode 308
03/09/2025
Stock Talk Podcast Episode 307
26/08/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.